{"id":71162,"date":"2026-10-15T15:45:33","date_gmt":"2026-10-15T10:15:33","guid":{"rendered":"https:\/\/www.equentis.com\/blog\/?p=71162"},"modified":"2026-10-15T15:45:42","modified_gmt":"2026-10-15T10:15:42","slug":"icici-lombard-q2-results-fy27-key-financial-highlights","status":"publish","type":"post","link":"https:\/\/www.equentis.com\/blog\/icici-lombard-q2-results-fy27-key-financial-highlights\/","title":{"rendered":"ICICI Lombard Q2 Results FY27: Key Financial Highlights"},"content":{"rendered":"<div id=\"bsf_rt_marker\"><\/div>\n<p class=\"wp-block-paragraph\">ICICI Lombard General Insurance reported a stronger September quarter, supported by growth in motor and health insurance premiums and higher investment income.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Key figures from the quarter ended September 2026 include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Net profit:<\/strong> \u20b9946 crore, up 15.5% year on year, according to Reuters.<\/li>\n\n\n\n<li><strong>Net premiums earned:<\/strong> \u20b96,652 crore, an increase of 17.7%.<\/li>\n\n\n\n<li><strong>Motor insurance:<\/strong> Net premium growth of 9%.<\/li>\n\n\n\n<li><strong>Retail health insurance:<\/strong> Net premiums increased 49.5%.<\/li>\n\n\n\n<li><strong>Combined ratio:<\/strong> 107%, compared with 105.1% a year earlier.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The combined ratio measures claims and operating expenses relative to premiums. A ratio above 100% indicates that underwriting costs exceed premiums earned, making this an important area for investors to monitor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The results show that premium growth and investment income supported profitability, but underwriting performance remains a concern.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">ICICI Lombard Share Price Target: What Three Brokerages Say<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Three brokerages have presented different views on ICICI Lombard shares after the Q2 results. Their target prices reflect different assumptions about future earnings, valuation and operating risks.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><th>Brokerage<\/th><th>Rating<\/th><th>Target price<\/th><\/tr><tr><td>Jefferies<\/td><td>Buy<\/td><td>\u20b92,050<\/td><\/tr><tr><td>HSBC<\/td><td>Hold<\/td><td>\u20b91,820<\/td><\/tr><tr><td>Motilal Oswal<\/td><td>Neutral<\/td><td>\u20b91,730<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Jefferies: Target Price of \u20b92,050<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Jefferies maintained its Buy rating with a target price of \u20b92,050. Its assessment reflects better-than-expected claims performance and encouraging growth commentary, particularly in retail health and two-wheeler insurance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The brokerage&#8217;s positive stance suggests that improving operating performance could support earnings growth. However, future returns will depend on whether premium growth translates into sustainable profitability.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">HSBC: Target Price of \u20b91,820<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">HSBC retained its Hold rating and revised its target price to \u20b91,820. Its more cautious stance highlights the importance of balancing improved operating performance against valuation and the sustainability of earnings.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A Hold rating generally indicates that the analyst sees a more limited risk-reward case at the prevailing price, although the precise reasoning depends on the full research report.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Motilal Oswal: Target Price of \u20b91,730<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Motilal Oswal maintained a Neutral rating with a target price of \u20b91,730. The brokerage raised its FY27 and FY28 profit estimates by up to 7% following the quarterly results.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Despite the improved earnings outlook, it highlighted potential regulatory uncertainty around insurance distribution norms and upcoming risk-based capital requirements. This suggests that stronger earnings alone may not be sufficient to justify a higher valuation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These target prices are analyst estimates, not guaranteed future prices. They may change as new results, regulations and market conditions emerge.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Opportunities and Risks for ICICI Lombard Investors<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">ICICI Lombard&#8217;s expansion in retail health insurance could support growth as demand for medical cover increases. Motor insurance also remains an important business segment, with premium growth supported by vehicle demand.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, investors should watch several risks:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Underwriting profitability:<\/strong> A combined ratio above 100% indicates that claims and expenses exceed premiums.<\/li>\n\n\n\n<li><strong>Competition:<\/strong> Insurers must balance premium growth with pricing discipline and claims management.<\/li>\n\n\n\n<li><strong>Regulatory changes:<\/strong> New capital and distribution requirements could affect operating costs and business strategy.<\/li>\n\n\n\n<li><strong>Investment income:<\/strong> A portion of reported profit depends on investment performance, which can vary across reporting periods.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The distinction between premium growth and profitable growth is particularly important. An insurer can sell more policies without improving underwriting margins if claims and operating expenses rise faster than premiums.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">ICICI Lombard&#8217;s Q2 FY27 results showed higher profit and strong growth in retail health insurance, while its combined ratio highlighted continuing underwriting pressure. Brokerages remain divided, with target prices ranging from \u20b91,730 to \u20b92,050.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Investors should evaluate these forecasts alongside the company&#8217;s earnings quality, claims performance, valuation and regulatory outlook. Brokerage targets can provide useful perspectives, but they should not replace independent research or an assessment of individual financial goals.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Frequently Asked Questions<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">1. What is the ICICI Lombard share price target after Q2 results?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Jefferies has a target of \u20b92,050, HSBC has a target of \u20b91,820, and Motilal Oswal has a target of \u20b91,730. These estimates reflect different views on earnings growth, valuation and risks. Target prices are forecasts, not guarantees, and may change as new information becomes available.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. How did ICICI Lombard perform in Q2 FY27?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">ICICI Lombard reported a 15.5% year-on-year increase in net profit to \u20b9946 crore, according to Reuters. Net premiums earned rose 17.7% to \u20b96,652 crore. Growth in motor and health insurance supported performance, although the combined ratio increased to 107%, highlighting underwriting pressure.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. Why did Jefferies maintain a Buy rating on ICICI Lombard?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Jefferies maintained its Buy rating with a \u20b92,050 target price, citing better-than-expected claims performance and positive growth commentary. Its assessment reflects the potential for stronger operating performance to support earnings. However, future results will depend on premium growth, claims costs, competition and broader market conditions.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">4. Why did HSBC retain a Hold rating on ICICI Lombard?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">HSBC retained a Hold rating with a revised target price of \u20b91,820. The rating reflects a more measured assessment of the stock&#8217;s risk-reward profile following the quarterly results. Investors should consult the full brokerage report to understand its valuation assumptions and the risks considered in the recommendation.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">5. Why is Motilal Oswal neutral on ICICI Lombard shares?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Motilal Oswal maintained a Neutral rating with a \u20b91,730 target price despite raising profit estimates for FY27 and FY28 by up to 7%. The brokerage highlighted potential regulatory risks involving distribution norms and risk-based capital requirements, which could affect the insurer&#8217;s costs and future profitability.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">6. What is ICICI Lombard&#8217;s combined ratio?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The combined ratio measures an insurer&#8217;s claims and operating expenses against premiums earned. A ratio below 100% generally indicates an underwriting profit, while a ratio above 100% indicates an underwriting loss. ICICI Lombard&#8217;s reported ratio of 107% makes claims management and operating efficiency important areas to monitor.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">7. Why is retail health insurance growth important for ICICI Lombard?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Retail health insurance can provide an important source of premium growth as households seek protection against medical expenses. ICICI Lombard&#8217;s retail health net premiums increased 49.5% year on year in Q2 FY27. However, sustainable growth also depends on pricing, claims experience, customer retention and the cost of acquiring policies.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">8. Does higher profit mean ICICI Lombard shares will rise?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">No. Higher profit does not guarantee a share price increase. Investors also consider valuations, future earnings expectations, underwriting profitability and broader market conditions. If the market has already priced in strong results, even a profitable quarter may not lead to further gains.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">9. What risks should investors watch in ICICI Lombard?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Key risks include rising claims costs, competition in motor and health insurance, regulatory changes and fluctuations in investment income. The combined ratio is particularly useful for assessing underwriting performance. Investors should also examine premium growth, earnings consistency and valuation when evaluating the company&#8217;s financial outlook.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">10. Are brokerage target prices reliable for making investment decisions?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Brokerage target prices are based on analysts&#8217; assumptions about future earnings, valuations and business risks. They can help investors compare different viewpoints, but they are not certain predictions. Investors should consider the underlying reasoning, the time horizon and their own financial circumstances rather than relying on a target price alone.<\/p>\n\n\n\n<p class=\"has-ast-global-color-5-color has-vivid-red-background-color has-text-color has-background has-link-color wp-elements-a377517bdd8f600e0c2e7efd2ef366fd wp-block-paragraph\">Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis \u2013 Research &amp; Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL &amp; certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ICICI Lombard General Insurance reported a stronger September quarter, supported by growth in motor and health insurance premiums and higher [&hellip;]<\/p>\n","protected":false},"author":25,"featured_media":71165,"comment_status":"closed","ping_status":"0","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[948],"tags":[],"class_list":["post-71162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock-market-news"],"_links":{"self":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/71162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/comments?post=71162"}],"version-history":[{"count":1,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/71162\/revisions"}],"predecessor-version":[{"id":71172,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/71162\/revisions\/71172"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/media\/71165"}],"wp:attachment":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/media?parent=71162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/categories?post=71162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/tags?post=71162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}